부산대학교 도서관

교내접속OFF
영문 바로가기
Home
통합검색
학술논문

학술논문

replay검색결과 돌아가기
search검색화면
CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study
Document Type
Article
Author
Munir, T.; Moreno, C.; Owen, C.; Follows, G.; Benjamini, O.; Janssens, A.; Levin, M.-D.; Osterborg, A.; Robak, T.; Simkovic, M.; Stevens, D.; Voloshin, S.; Vorobyev, V.; Yagci, M.; Ysebaert, L.; Qi, Q.; Caces, D.B.; Steele, A.; Schuier, N.; Baeten, K.; Niemann, C.; Kater, A.
Source
In: Clinical Lymphoma, Myeloma and Leukemia, Proceedings of the Society of Hematologic Oncology 2022 Annual Meeting. (Clinical Lymphoma, Myeloma and Leukemia, October 2022, 22:S264-S265)
Subject
Language
English
ISSN
21522669
21522650

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

메일 발송

이메일

폴더 추가